Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2003 1
2006 2
2007 2
2009 2
2010 2
2011 3
2012 5
2013 4
2014 4
2015 7
2016 3
2018 4
2019 6
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

45 results
Results by year
Filters applied: . Clear all
Page 1
Altered mental status in a young male.
Pols AD, van Dam PS, van den Berk GE. Pols AD, et al. Among authors: van den berk ge. Neth J Med. 2012 Aug;70(6):281, 284. Neth J Med. 2012. PMID: 22859421 Free article. No abstract available.
Improving HIV-related care through eHealth.
van den Berk GEL, Leoni MC, Behrens GMN, Taljaard J, Arends JE. van den Berk GEL, et al. Lancet HIV. 2020 Jan;7(1):e8-e10. doi: 10.1016/S2352-3018(19)30348-0. Epub 2019 Nov 24. Lancet HIV. 2020. PMID: 31776102 No abstract available.
Health-related quality of life among adult HIV positive patients: assessing comprehensive themes and interrelated associations.
den Daas C, van den Berk GEL, Kleene M-T, de Munnik ES, Lijmer JG, Brinkman K. den Daas C, et al. Among authors: van den berk gel. Qual Life Res. 2019 Oct;28(10):2685-2694. doi: 10.1007/s11136-019-02203-y. Epub 2019 May 16. Qual Life Res. 2019. PMID: 31098796 Free PMC article.
Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial.
Boerekamps A, De Weggheleire A, van den Berk GE, Lauw FN, Claassen MAA, Posthouwer D, Bierman WF, Hullegie SJ, Popping S, van de Vijver DACM, Dofferhoff ASM, Kootstra GJ, Leyten EM, den Hollander J, van Kasteren ME, Soetekouw R, Ammerlaan HSM, Schinkel J, Florence E, Arends JE, Rijnders BJA. Boerekamps A, et al. Among authors: van den berk ge. Lancet Gastroenterol Hepatol. 2019 Apr;4(4):269-277. doi: 10.1016/S2468-1253(18)30414-X. Epub 2019 Jan 17. Lancet Gastroenterol Hepatol. 2019. PMID: 30660617 Clinical Trial.
Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study.
el Moussaoui R, de Borgie CA, van den Broek P, Hustinx WN, Bresser P, van den Berk GE, Poley JW, van den Berg B, Krouwels FH, Bonten MJ, Weenink C, Bossuyt PM, Speelman P, Opmeer BC, Prins JM. el Moussaoui R, et al. Among authors: van den berk ge. BMJ. 2006 Jun 10;332(7554):1355. doi: 10.1136/bmj.332.7554.1355. BMJ. 2006. PMID: 16763247 Free PMC article. Clinical Trial.
8 weeks of sofosbuvir/ledipasvir is effective in DAA-naive non-cirrhotic HCV genotype 4 infected patients (HEPNED-001 study).
Boerekamps A, Vanwolleghem T, van der Valk M, van den Berk GE, van Kasteren M, Posthouwer D, Dofferhoff ASM, van Hoek B, Ramsoekh D, Koopsen J, Schinkel J, Florence E, Arends JE, Rijnders BJ. Boerekamps A, et al. Among authors: van den berk ge. J Hepatol. 2019 Mar;70(3):554-557. doi: 10.1016/j.jhep.2018.10.032. Epub 2018 Dec 5. J Hepatol. 2019. PMID: 30527953 No abstract available.
The effect of switching protease inhibitors to raltegravir on endothelial function, in HIV-infected patients.
Krikke M, Tesselaar K, van den Berk GEL, Otto SA, Freriks LH, van Lelyveld SFL, Visseren FJL, Hoepelman AIM, Arends JE. Krikke M, et al. Among authors: van den berk gel. HIV Clin Trials. 2018 Apr;19(2):75-83. doi: 10.1080/15284336.2018.1455366. HIV Clin Trials. 2018. PMID: 29770748
Outcome effects of antiretroviral drug combinations in HIV-positive patients with chemotherapy for lymphoma: a retrospective analysis.
Sombogaard F, Franssen EJF, Terpstra WE, Kerver ED, van den Berk GEL, Crul M. Sombogaard F, et al. Among authors: van den berk gel. Int J Clin Pharm. 2018 Oct;40(5):1402-1408. doi: 10.1007/s11096-018-0620-1. Epub 2018 Jun 12. Int J Clin Pharm. 2018. PMID: 29948741 Free PMC article.
Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy.
Boerekamps A, van den Berk GE, Lauw FN, Leyten EM, van Kasteren ME, van Eeden A, Posthouwer D, Claassen MA, Dofferhoff AS, Verhagen DWM, Bierman WF, Lettinga KD, Kroon FP, Delsing CE, Groeneveld PH, Soetekouw R, Peters EJ, Hullegie SJ, Popping S, van de Vijver DAMC, Boucher CA, Arends JE, Rijnders BJ. Boerekamps A, et al. Among authors: van den berk ge. Clin Infect Dis. 2018 Apr 17;66(9):1360-1365. doi: 10.1093/cid/cix1007. Clin Infect Dis. 2018. PMID: 29186320
Incidence of darunavir hypersensitivity in different clinical cohorts.
Arends JE, van den Berk GE. Arends JE, et al. Among authors: van den berk ge. AIDS. 2015 Oct 23;29(16):2214-5. doi: 10.1097/QAD.0000000000000836. AIDS. 2015. PMID: 26544586 No abstract available.
45 results
Jump to page
Feedback